BAM
ALXN

Bellevue Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bellevue Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-169
Closed -$31K – 609
2021
Q2 		$31K Hold
169
– – 0.02% 235
2021
Q1 		$26K Hold
169
– – 0.02% 261
2020
Q4 		$27K Hold
169
– – 0.02% 245
2020
Q3 		$19K Buy
169
+30
+22% +$3.24K 0.01% 265
2020
Q2 		$16K Hold
139
– – 0.02% 289
2020
Q1 		$15K Buy
+139
New +$13.6K 0.02% 299

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return